These findings offer new insights into the role of AEC‐II‐derived exosomal Rmrp in the pathogenesis of SII and secondary pneumonia and highlight Rmrp as a promising therapeutic target for improving sepsis outcomes. The gene discussed is RMRP; the disease is susceptibility to pneumonia measurement.